SCHEMBL3384791

SCHEMBL3384791

O=C(O)Nc1cc(O)c(Cl)c(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 2/20 0.47
THRB P10828 2/20 0.47
HPGD P15428 2/20 0.45
TSHR P16473 2/20 0.45
HSD17B10 Q99714 2/20 0.45
ALDH1A1 P00352 1/20 0.45
HSP90AA1 P07900 1/20 0.41
CYP3A4 P08684 1/20 0.41
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39
KMT2A Q03164 2/20 0.39
DHODH Q02127 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
EPHX1 P07099 1/20 0.38
EPHX2 P34913 1/20 0.38
P2RY1 P47900 1/20 0.37
P2RX1 P51575 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2097418 0.87 THRA (0.44) THRATHRBHPGDHSD17B10ALDH1A1
SCHEMBL1706750 0.81 DHODH (0.54) THRATHRBHPGDTSHRHSD17B10
SCHEMBL13473624 0.78 TGM2 (0.46) HPGDTSHRHSD17B10ALDH1A1MAPT
SCHEMBL17603210 0.76 EPHX1 (0.52) TSHRHSD17B10ALDH1A1CYP3A4RAB9A
SCHEMBL4683057 0.76 MAPT (0.55) THRATHRBHSD17B10ALDH1A1RAB9A
SCHEMBL23537568 0.75 NPC1 (0.42) THRATHRBTSHRALDH1A1RAB9A
SCHEMBL17825613 0.75 MAPT (0.43) THRATHRBHPGDALDH1A1RAB9A
SCHEMBL12908955 0.74 CA12 (0.40) HPGDTSHRHSD17B10ALDH1A1HSP90AA1
SCHEMBL711831 0.72 MEN1 (0.61) ALDH1A1RAB9AMEN1MAPTKMT2A
SCHEMBL11006451 0.72 EPHX1 (0.61) ALDH1A1RAB9ANPC1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016042172-A1 IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2016-03-24 WO disclosed
EP-2212332-B1 SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF BAYER IP GMBH (DE) 2012-10-24 EP disclosed
EP-2212332-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2010-08-04 EP disclosed
WO-2009033581-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-03-19 WO disclosed